SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001437749-20-002083
Filing Date
2020-02-07
Accepted
2020-02-07 17:23:10
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM 424B3 atos20200204_424b3.htm 424B3 346146
2 logo.jpg GRAPHIC 18903
  Complete submission text file 0001437749-20-002083.txt   373314
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-220572 | Film No.: 20588487
SIC: 2834 Pharmaceutical Preparations